Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalInternational Journal of Cardiology
DOIs
Publication statusPublished - 2012

Cite this